New combo therapy aims to boost breast cancer treatment before surgery
Disease control
Recruiting now
This study tests a new treatment called NECVAX-NEO1 added to standard therapy for people with triple-negative breast cancer. The goal is to see if it is safe and helps control the disease before and after surgery. About 12 participants will receive the treatment alongside chemoth…
Phase: PHASE1, PHASE2 • Sponsor: NEC Bio B.V • Aim: Disease control
Last updated May 14, 2026 12:03 UTC